| Net Cash Provided by (Used in) Operating Activities |
-33.9K |
USD |
-14.4% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
33.9K |
USD |
+49.7% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
101M |
shares |
+855% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
64.5K |
USD |
+24.5% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
64.5K |
USD |
+24.5% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
64.5K |
USD |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
5M |
shares |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
202K |
USD |
-0.09% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |